Propiedad y actividad de insiders de Harmony Biosciences Holdings, Inc. (HRMY): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $42.21 |
| Capitalización | $2.4B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-08 | Budur Kumar | M-Exempt | 10,754 | $326K |
| 2026-09-08 | Budur Kumar | M-Exempt | 10,754 | $326K |
| 2026-09-08 | Budur Kumar | M-Exempt | 12,200 | $374K |
| 2026-09-08 | Budur Kumar | M-Exempt | 12,200 | $374K |
| 2026-09-04 | Budur Kumar | S-Sale | 5,500 | $231K |
| 2026-09-08 | Budur Kumar | S-Sale | 4,500 | $190K |
| 2026-09-08 | Budur Kumar | S-Sale | 1,000 | $43K |
| 2026-09-08 | Budur Kumar | S-Sale | 22,954 | $989K |
| 2026-07-16 | Mollichella Stephen M. | |||
| 2026-07-16 | Mollichella Stephen M. | 20,750 | $763K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $83.5M | $24.5M | $228.6M | $234.3M | $243.8M | $311.7M | $453.0M | $752.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $79.3M | $41.8M | $14.2M | $22.8M |
| Cuentas por Cobrar | 0 | $4.3M | $22.2M | $34.8M | $54.7M | $74.1M | $83.0M | $96.8M |
| Inventario | 0 | $1.1M | $3.8M | $4.4M | $4.3M | $5.4M | $7.2M | $5.4M |
| Activos Corrientes | $86.7M | $31.5M | $262.9M | $284.4M | $400.3M | $451.1M | $579.3M | $907.0M |
| Inmovilizado Material | $1.6M | $1.3M | $938000 | $4.1M | $573000 | $371000 | $3.4M | $5.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $72.2M | $162.3M | $143.9M | $161.0M | $137.1M | $113.3M | $89.4M |
| Activos Totales | $89.3M | $106.7M | $427.1M | $433.4M | $673.9M | $811.4M | $999.2M | $1.27B |
| Cuentas por Pagar | $1.5M | $6.4M | $2.6M | $1.0M | $3.8M | $17.7M | $13.7M | $17.7M |
| Deuda a Corto | 0 | 0 | 0 | $2.0M | $2.0M | $15.0M | $16.2M | $86.9M |
| Pasivos Corrientes | $7.2M | $19.9M | $134.5M | $53.8M | $78.9M | $163.8M | $175.1M | $252.1M |
| Deuda a Largo | $324.2M | $97.9M | $194.2M | $190.0M | $189.6M | $178.6M | $163.0M | $148.2M |
| Pasivos Totales | $7.8M | $118.3M | $329.9M | $246.9M | $271.0M | $344.5M | $340.0M | $401.4M |
| Reservas | -$242.7M | -$422.9M | -$488.2M | -$453.6M | -$272.1M | -$143.3M | $2.2M | $160.9M |
| Patrimonio Neto | $81.5M | -$11.6M | $97.2M | $186.5M | $402.8M | $467.0M | $659.2M | $870.2M |
| Deuda Total | $324.2M | $97.9M | $194.2M | $195.7M | $191.6M | $193.6M | $181.4M | $239.6M |
| Deuda Neta | $240.7M | $73.5M | -$34.4M | -$38.6M | -$131.5M | -$159.9M | -$285.8M | -$535.8M |
| Capital Circulante | $79.5M | $11.6M | $128.4M | $230.7M | $321.4M | $287.3M | $404.2M | $654.9M |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 3.48 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 5.23 |
Rentabilidad
| Rentabilidad sobre capital | 20.06% |
| Rentabilidad sobre capital invertido | 14.96% |
| Rentabilidad sobre activos | 13.20% |
| Margen bruto | 75.42% |
| Margen operativo | 24.03% |
| Margen neto | 18.88% |
Empresas relacionadas: ABCL · AUPH · BHVN · CLDX · IMCR · JANX · MNKD
Explorar sector: Healthcare · Biotechnology
Más secciones de HRMY: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones